Downregulated levels of SLC2A10 in lung cancer indicate a poor prognosis and increased aggressiveness of tumors, suggesting that SLC2A10 may play a crucial role in the progression of cancer (Jian et al., 2021). The gene discussed is SLC2A10; the disease is lung cancer.